Sugi Predict

Sugi Predict / Compounds / SCHEMBL12207331

SCHEMBL12207331

SCHEMBL12207331

CC(C)(C)c1nc2ccccc2nc1-c1ccc(N(c2ccccc2)c2ccc(N(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.46
▸ AKT2 P31751 1/20 0.46
▸ TDP1 Q9NUW8 3/20 0.45
▸ KDM4E B2RXH2 7/20 0.41
▸ L3MBTL1 Q9Y468 6/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ LMNA P02545 3/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ GAA P10253 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PDE10A Q9Y233 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ RAD51 Q06609 1/20 0.38
▸ PDK1 Q15118 1/20 0.37
▸ NOX1 Q9Y5S8 1/20 0.36
▸ PSMB5 P28074 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724670 1.00 AKT1 (0.46) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL12146729 1.00 AKT1 (0.46) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL12146726 0.98 AKT1 (0.45) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL12146718 0.95 AKT1 (0.49) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL12146712 0.95 AKT1 (0.49) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL10315133 0.88 NPC1 (0.42) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL10315222 0.86 NPC1 (0.46) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL12207597 0.85 KDM4E (0.38) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL19162664 0.85 AKT1 (0.57) AKT1AKT2TDP1KDM4EL3MBTL1
SCHEMBL13222016 0.85 AKT1 (0.56) AKT1AKT2TDP1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8471017-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO. LTD. (JP) 2013-06-25 — — US disclosed
US-8471017-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO. LTD. (JP) 2013-06-25 — — US disclosed
US-20110248254-A1 QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-13 — — US disclosed
US-20110248254-A1 QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-13 — — US disclosed
US-8008489-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-08-30 — — US disclosed
US-8008489-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-08-30 — — US disclosed
US-20100141130-A1 QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-10 — — US disclosed
US-20100141130-A1 QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-10 — — US disclosed
US-7696348-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORIES CO., LTD. (JP) 2010-04-13 — — US disclosed
US-7696348-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORIES CO., LTD. (JP) 2010-04-13 — — US disclosed
US-20070222374-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-09-27 — — US disclosed
US-20070222374-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100141130-A1 QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE NDUFA9, MT-ND1, NQO2 AKT1 4116/4885AKT2 4624/4885TDP1 1195/4885
US-20070222374-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative NDUFA9, MT-ND1, NQO2 AKT1 4116/4885AKT2 4624/4885TDP1 1195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.